Conclusion: NLRC5, LCP2, TMEM229B, and FCRL4 are potential antigens for ESCC mRNA vaccines, and such vaccines may be more suitable for IS2 patients. This evidence concerns the gene TMEM229B and esophageal squamous cell carcinoma.